These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 19145698)

  • 1. Dismissal of investor fraud claim over HIV drug reversed.
    AIDS Policy Law; 2008 Nov; 23(12):8. PubMed ID: 19145698
    [No Abstract]   [Full Text] [Related]  

  • 2. Patent infringement. Generic HIV drugmaker's patent claim is time-barred.
    AIDS Policy Law; 2003 Aug; 18(16):6. PubMed ID: 14626916
    [No Abstract]   [Full Text] [Related]  

  • 3. Remarks at the Food and Drug Law Institute's 48th Annual Conference.
    Niedelman SM
    Food Drug Law J; 2005; 60(2):117-26. PubMed ID: 16097089
    [No Abstract]   [Full Text] [Related]  

  • 4. Off-label or off-limits?
    Ratner M; Gura T
    Nat Biotechnol; 2008 Aug; 26(8):867-75. PubMed ID: 18688236
    [No Abstract]   [Full Text] [Related]  

  • 5. Indian company seeks US approval for generic AIDS drugs.
    Nature; 2004 Aug; 430(7001):716. PubMed ID: 15306779
    [No Abstract]   [Full Text] [Related]  

  • 6. Is Noerr-Pennington immunity still a viable defense against antitrust claims arising from Hatch-Waxman litigation?
    Steinhauer EH
    Food Drug Law J; 2006; 61(4):679-700. PubMed ID: 17180769
    [No Abstract]   [Full Text] [Related]  

  • 7. Remarks by the Commissioner of Food and Drugs.
    Kessler DA
    Food Drug Law J; 1995; 50(2):327-34. PubMed ID: 10343001
    [No Abstract]   [Full Text] [Related]  

  • 8. WHO pulls Indian generics off AIDS drugs list.
    Nat Med; 2004 Sep; 10(9):885. PubMed ID: 15340402
    [No Abstract]   [Full Text] [Related]  

  • 9. Bolar agrees to guilty plea in generic drug probe.
    Wagner M
    Mod Healthc; 1991 Mar; 21(9):17. PubMed ID: 10109180
    [No Abstract]   [Full Text] [Related]  

  • 10. Can the U.S. Food and Drug Administration act against global frauds? The extraterritorial effect of Food and Drug Administration sanctions after Small v. United States.
    O'Reilly J
    Food Drug Law J; 2005; 60(3):347-60. PubMed ID: 16304742
    [No Abstract]   [Full Text] [Related]  

  • 11. Targeting drug companies' bottom line.
    Prescrire Int; 2011 Jan; 20(112):25. PubMed ID: 21462792
    [No Abstract]   [Full Text] [Related]  

  • 12. Genta sued over NDA withdrawal.
    Mack GS
    Nat Biotechnol; 2004 Jul; 22(7):788-9. PubMed ID: 15229523
    [No Abstract]   [Full Text] [Related]  

  • 13. Prescription drug advertising--should states regulate what is false and misleading?
    Shaeffer J
    Food Drug Law J; 2003; 58(4):629-48. PubMed ID: 15027454
    [No Abstract]   [Full Text] [Related]  

  • 14. FDA, companies test RFID tracking to prevent drug counterfeiting.
    James JS
    AIDS Treat News; 2005 Dec; (417):5-8. PubMed ID: 16541509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Doctor explains why he blew the whistle.
    Petersen M
    N Y Times Web; 2003 Mar; ():C1, C2. PubMed ID: 12812161
    [No Abstract]   [Full Text] [Related]  

  • 16. The problem of new uses.
    Eisenberg RS
    Yale J Health Policy Law Ethics; 2005; 5(2):717-39. PubMed ID: 16052897
    [No Abstract]   [Full Text] [Related]  

  • 17. Disqualification of a clinical investigator--FDA. Final rule.
    Fed Regist; 1997 Sep; 62(172):46875-6. PubMed ID: 10173286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FDA to steer nanotech.
    Fox JL
    Nat Biotechnol; 2008 Oct; 26(10):1060. PubMed ID: 18846060
    [No Abstract]   [Full Text] [Related]  

  • 19. Trouble at the office.
    Allison M
    Nat Biotechnol; 2008 Sep; 26(9):967-9. PubMed ID: 18779797
    [No Abstract]   [Full Text] [Related]  

  • 20. Bush tails follow-ons.
    Fox J
    Nat Biotechnol; 2008 Apr; 26(4):366. PubMed ID: 18392007
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 19.